Menstrual cycle phase and responses to drugs of abuse in humans

Drug and Alcohol Dependence

Volumn 84, Issue 1, 2006, Pages 1-13

  Terner, Jolan M ^a   de Wit, Harriet ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Drugs of abuse; Menstrual cycle; Mood; Physiological effects; Women

Indexed keywords

ALCOHOL; ALPRAZOLAM; AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; BUTORPHANOL; CAFFEINE; CANNABIS; COCAINE; DEXAMPHETAMINE; DIAZEPAM; DRONABINOL; ESTROGEN; FOLLITROPIN; LUTEINIZING HORMONE; NALBUPHINE; NICOTINE; PROGESTERONE;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ANTINOCICEPTION; ANXIETY; AREA UNDER THE CURVE; BASAL BODY TEMPERATURE; CIGARETTE SMOKING; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DISCRIMINATIVE STIMULUS; DRUG ABSORPTION; DRUG ABUSE; DRUG CLEARANCE; DRUG MEGADOSE; DRUG POTENCY; DRUG RESPONSE; ESTROGEN BLOOD LEVEL; ESTRUS CYCLE; EUPHORIA; FIRST PASS EFFECT; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HEART RATE; HUMAN; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; MEMORY DISORDER; MENSTRUAL CYCLE; MESOLIMBIC DOPAMINERGIC SYSTEM; MOOD CHANGE; NEGATIVE FEEDBACK; NONHUMAN; OVARIECTOMY; OVULATION; PAIN ASSESSMENT; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PROESTRUS; PROGESTERONE BLOOD LEVEL; REVIEW; REWARD; SACCADIC EYE MOVEMENT; SYSTOLIC BLOOD PRESSURE; TRANQUILIZING ACTIVITY; VISUAL ANALOG SCALE; WITHDRAWAL SYNDROME;

CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HUMANS; MENSTRUAL CYCLE; SUBSTANCE-RELATED DISORDERS;

CANNABIS SATIVA;

EID: 33646341586     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2005.12.007     Document Type: Review

References (86)

1. Allen S.S., Hatsukami D., Christianson D., and Brown S. Effects of transdermal nicotine on craving, withdrawal and premenstrual symptomatology in short-term smoking abstinence during different phases of the menstrual cycle. Nicotine Tob. Res. 2 (2000) 231-241
2. Allen S.S., Hatsukami D.K., Christianson D., and Nelson D. Withdrawal and pre-menstrual symptomatology during the menstrual cycle in short-term smoking abstinence: effects of menstrual cycle on smoking abstinence. Nicotine Tob. Res. 1 (1999) 129-142
3. American Psychiatric Association, 1987. Diagnostic and Statistical Manual of Mental Disorders, IV ed. Washington, DC.
4. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, IV ed. Washington, DC.
5. Becker J.B. Estrogen rapidly potentiates amphetamine-induced striatal dopamine release and rotational behavior during microdialysis. Neurosci. Lett. 118 (1990) 169-171
6. Becker J.B. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol. Biochem. Behav. 64 (1999) 803-812
7. Becker J.B., Arnold A.P., Berkley K.J., Blaustein J.D., Eckel L.A., Hampson E., Herman J.P., Marts S., Sadee W., Steiner M., Taylor J., and Young E. Strategies and methods for research on sex differences in brain and behavior. Endocrinology 146 (2005) 1650-1673
8. Becker J.B., and Cha J.H. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behav. Brain Res. 35 (1989) 117-125
9. Bell E.C., Baker G.B., Poag C., Bellavance F., Khudabux J., and Le Melledo J.M. Response to flumazenil in the late luteal phase and follicular phase of the menstrual cycle in healthy control females. Psychopharmacology (Berl.) 172 (2004) 248-254
10. Berne R.M., and Levy M.N. Principles of Physiology (2000), Mosby, St. Louis, MO
11. Bonnin A., Fernandez-Ruiz J.J., Martin M., Rodriguez de Fonseca F., Hernandez M.L., and Ramos J.A. Delta 9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens. J. Neural. Transm. Gen. Sect. 92 (1993) 81-95
12. Bruguerolle B. Caffeine kinetic changes during the oestrous cycle in rats. Fundam. Clin. Pharmacol. 6 (1992) 45-48
13. Centonze D., Picconi B., Baunez C., Borrelli E., Pisani A., Bernardi G., and Calabresi P. Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors. Neuropsychopharmacology 26 (2002) 164-175
14. Correa C.L., and Oga S. Effects of the menstrual cycle of white women on ethanol toxicokinetics. J. Stud. Alcohol. 65 (2004) 227-231
15. Coutelle C., Hohn B., Benesova M., Oneta C.M., Quattrochi P., Roth H.J., Schmidt-Gayk H., Schneeweiss A., Bastert G., and Seitz H.K. Risk factors in alcohol associated breast cancer: alcohol dehydrogenase polymorphism and estrogens. Int. J. Oncol. 25 (2004) 1127-1132
16. Crippens D., White M.L., George M.A., Jaworski J.N., Brunner L.J., Lancaster F.E., and Gonzales R.A. Gender differences in blood levels, but not brain levels, of ethanol in rats. Alcohol. Clin. Exp. Res. 23 (1999) 414-420
17. Daniel J.M., Winsauer P.J., Brauner I.N., and Moerschbaecher J.M. Estrogen improves response accuracy and attenuates the disruptive effects of delta9-THC in ovariectomized rats responding under a multiple schedule of repeated acquisition and performance. Behav. Neurosci. 116 (2002) 989-998
18. de Wit H., and Rukstalis M. Acute effects of triazolam in women: relationships with progesterone, estradiol and allopregnanolone. Psychopharmacology (Berl.) 130 (1997) 69-78
19. Donny E.C., Caggiula A.R., Rowell P.P., Gharib M.A., Maldovan V., Booth S., Mielke M.M., Hoffman A., and McCallum S. Nicotine self-administration in rats: estrous cycle effects, sex differences and nicotinic receptor binding. Psychopharmacology (Berl.) 151 (2000) 392-405
20. Epperson C.N., O'Malley S., Czarkowski K.A., Gueorguieva R., Jatlow P., Sanacora G., Rothman D.L., Krystal J.H., and Mason G.F. Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy. Biol. Psychiatry 57 (2005) 44-48
21. Evans S.M., and Foltin R.W. Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology 31 (2006) 659-674
22. Evans S.M., Haney M., and Foltin R.W. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl.) 159 (2002) 397-406
23. Evans S.M., Haney M., Levin F.R., Foltin R.W., and Fischman M.W. Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam. Neuropsychopharmacology 19 (1998) 499-516
24. Fernandez-Guasti A., and Picazo O. The actions of diazepam and serotonergic anxiolytics vary according to the gender and the estrous cycle phase. Pharmacol. Biochem. Behav. 37 (1990) 77-81
25. Fernandez-Guasti A., and Picazo O. Anxiolytic actions of diazepam, but not of buspirone, are influenced by gender and the endocrine stage. Behav. Brain Res. 88 (1997) 213-218
26. Fillingim R.B., and Ness T.J. Sex-related hormonal influences on pain and analgesic responses. Neurosci. Biobehav. Rev. 24 (2000) 485-501
27. Ford M.M., Eldridge J.C., and Samson H.H. Microanalysis of ethanol self-administration: estrous cycle phase-related changes in consumption patterns. Alcohol. Clin. Exp. Res. 26 (2002) 635-643
28. Forger N.G., and Morin L.P. Reproductive state modulates ethanol intake in rats: effects of ovariectomy, ethanol concentration, estrous cycle and pregnancy. Pharmacol. Biochem. Behav. 17 (1982) 323-331
29. Franklin T.R., Napier K., Ehrman R., Gariti P., O'Brien C.P., and Childress A.R. Retrospective study: influence of menstrual cycle on cue-induced cigarette craving. Nicotine Tob. Res. 6 (2004) 171-175
30. Freitag W.J., and Adesso V.J. Mood effects of alcohol and expectancies across the menstrual cycle. Alcohol. 10 (1993) 291-298
31. Gear R.W., Paul S., Miaskowski C., Gordon N.C., Paul S.M., Heller P.H., and Levine J.D. Kappa-opioids produce significantly greater analgesia in women than in men. Nat. Med. 2 (1996) 1248-1250
32. Grant K.A., Azarov A., Shively C.A., and Purdy R.H. Discriminative stimulus effects of ethanol and 3 alpha-hydroxy-5 alpha-pregnan-20-one in relation to menstrual cycle phase in cynomolgus monkeys (Macaca fascicularis). Psychopharmacology (Berl.) 130 (1997) 59-68
33. Green K.L., Szeliga K.T., Bowen C.A., Kautz M.A., Azarov A.V., and Grant K.A. Comparison of ethanol metabolism in male and female cynomolgus macaques (Macaca fascicularis). Alcohol. Clin. Exp. Res. 23 (1999) 611-616
34. Griffin M.L., Mendelson J.H., Mello N.K., and Lex B.W. Marihuana use across the menstrual cycle. Drug Alcohol Depend. 18 (1986) 213-224
35. Griffin J.E., and Ojeda S.R. Textbook of Endocrine Physiology (2004), Oxford University Press, New York
36. Haddad L., Milke P., Zapata L., de la Fuente J.R., Vargas-Vorackova F., Lorenzana-Jimenez M., Corte G., Tamayo J., Kaplan M., Marquez M., and Kershenobich D. Effect of the menstrual cycle in ethanol pharmacokinetics. J. Appl. Toxicol. 18 (1998) 15-18
37. Harvey S.M., and Beckman L.J. Cyclic fluctuation in alcohol consumption among female social drinkers. Alcohol. Clin. Exp. Res. 9 (1985) 465-467
38. Hay W.M., Nathan P.E., Heermans H.W., and Frankenstein W. Menstrual cycle, tolerance and blood alcohol level discrimination ability. Addict Behav. 9 (1984) 67-77
39. Holdstock L., and de Wit H. Effects of ethanol at four phases of the menstrual cycle. Psychopharmacology (Berl.) 150 (2000) 374-382
40. Hu M., Crombag H.S., Robinson T.E., and Becker J.B. Biological basis of sex differences in the propensity to self-administer cocaine. Neuropsychopharmacology 29 (2004) 81-85
41. Justice A.J., and de Wit H. Acute effects of d-amphetamine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl.) 145 (1999) 67-75
42. Justice A.J., and de Wit H. Acute effects of estradiol pretreatment on the response to d-amphetamine in women. Neuroendocrinology 71 (2000) 51-59
43. Justice A.J., and de Wit H. Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol. Biochem. Behav. 66 (2000) 509-515
44. Kamimori G.H., Joubert A., Otterstetter R., Santaromana M., and Eddington N.D. The effect of the menstrual cycle on the pharmacokinetics of caffeine in normal, healthy eumenorrheic females. Eur. J. Clin. Pharmacol. 55 (1999) 445-449
45. Kamimori G.H., Sirisuth N., Greenblatt D.J., and Eddington N.D. The influence of the menstrual cycle on triazolam and indocyanine green pharmacokinetics. J. Clin. Pharmacol. 40 (2000) 739-744
46. Kaufman M.J., Levin J.M., Maas L.C., Kukes T.J., Villafuerte R.A., Dostal K., Lukas S.E., Mendelson J.H., Cohen B.M., and Renshaw P.F. Cocaine-induced cerebral vasoconstriction differs as a function of sex and menstrual cycle phase. Biol. Psychiatry 49 (2001) 774-781
47. Kharasch E.D., Mautz D., Senn T., Lentz G., and Cox K. Menstrual cycle variability in midazolam pharmacokinetics. J. Clin. Pharmacol. 39 (1999) 275-280
48. Kouri E.M., Lundahl L.H., Borden K.N., McNeil J.F., and Lukas S.E. Effects of oral contraceptives on acute cocaine response in female volunteers. Pharmacol. Biochem. Behav. 74 (2002) 173-180
49. Leibenluft E., Fiero P.L., and Rubinow D.R. Effects of the menstrual cycle on dependent variables in mood disorder research. Arch. Gen. Psychiatry 51 (1994) 761-781
50. Levesque D., and Di Paolo T. Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17 beta-estradiol. Neurosci. Lett. 88 (1988) 113-118
51. Lex B.W., Mendelson J.H., Bavli S., Harvey K., and Mello N.K. Effects of acute marijuana smoking on pulse rate and mood states in women. Psychopharmacology (Berl.) 84 (1984) 178-187
52. Linnoila M., Erwin C.W., Ramm D., Cleveland W.P., and Brendle A. Effects of alcohol on psychomotor performance of women: interaction with menstrual cycle. Alcohol Clin. Exp. Res. 4 (1980) 302-305
53. Logue P.E., Linnoila M., Wallman L., and Erwin C.W. Effects of ethanol and psychomotor tests on state anxiety: interaction with menstrual cycle in women. Percept. Mot. Skills 52 (1981) 643-648
54. Lukas S.E., Sholar M., Lundahl L.H., Lama X., Kouri E., Wines J.D., Kragie L., and Mendelson J.H. Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology (Berl.) 125 (1996) 346-354
55. Marks J.L., Hair C.S., Klock S.C., Ginsburg B.E., and Pomerleau C.S. Effects of menstrual phase on intake of nicotine, caffeine, and alcohol and non-prescribed drugs in women with late luteal phase dysphoric disorder. J. Subst. Abuse. 6 (1994) 235-243
56. Marks J.L., Pomerleau C.S., and Pomerleau O.F. Effects of menstrual phase on reactivity to nicotine. Addict. Behav. 24 (1999) 127-134
57. Marshall A.W., Kingstone D., Boss M., and Morgan M.Y. Ethanol elimination in males and females: relationship to menstrual cycle and body composition. Hepatology 3 (1983) 701-706
58. Masson C.L., and Gilbert D.G. Cardiovascular and mood responses to quantified doses of cigarette smoke in oral contraceptive users and nonusers. J. Behav. Med. 22 (1999) 589-604
59. McAuley J.W., and Friedman C.I. Influence of endogenous progesterone on alprazolam pharmacodynamics. J. Clin. Psychopharmacol. 19 (1999) 233-239
60. Mello N.K., Bree M.P., and Mendelson J.H. Alcohol and food self-administration by female Macaque monkeys as a function of menstrual cycle phase. Physiol. Behav. 36 (1986) 959-966
61. Mendelson J.H., Mello N.K., Sholar M.B., Siegel A.J., Kaufman M.J., Levin J.M., Renshaw P.F., and Cohen B.M. Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle. Neuropsychopharmacology 21 (1999) 294-303
62. Mendelson J.H., Sholar M.B., Siegel A.J., and Mello N.K. Effects of cocaine on luteinizing hormone in women during the follicular and luteal phases of the menstrual cycle and in men. J. Pharmacol. Exp. Ther. 296 (2001) 972-979
63. Morissette M., and Di Paolo T. Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites. J. Neurochem. 60 (1993) 1876-1883
64. National Institutes of Health, 1994. NIH Guidelines on the Inclusion of Women and Minorities in Clinical Research. NIH Guide, vol. 23 (http://grants.nih.gov/grants/guide/notice-files/not94-100.html, accessed on May 10, 2005).
65. Nordstrom A.L., Olsson H., and Halldin C. A PET study of D2 dopamine receptor density at different phases of the menstrual cycle. Psychiatry Res. 83 (1998) 1-6
66. Nyberg S., Wahlstrom G., Backstrom G., and Sundstrom-Poromaa I. Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual dysphoric disorder. Psychoneuroendocrinology 29 (2004) 767-777
67. Penetar D.M., Kouri E.M., Gross M.M., McCarthy E.M., Rhee C.K., Peters E.N., and Lukas S.E. Transdermal nicotine alters some of marihuana's effects in male and female volunteers. Drug Alcohol Depend. 79 (2005) 211-223
68. Perkins K.A., Levine M., Marcus M., Shiffman S., D'Amico D., Miller A., and Keins A. Tobacco withdrawal in women and menstrual cycle phase. J. Consult. Clin. Psychol. 68 (2000) 176-180
69. Pomerleau C.S., Cole P.A., Lumley M.A., Marks J.L., and Pomerleau O.F. Effects of menstrual phase on nicotine, alcohol, and caffeine intake in smokers. J. Subst. Abuse. 6 (1994) 227-234
70. Roberts A.J., Smith A.D., Weiss F., Rivier C., and Koob G.F. Estrous cycle effects on operant responding for ethanol in female rats. Alcohol. Clin. Exp. Res. 22 (1998) 1564-1569
71. Robinson D.L., Brunner L.J., and Gonzales R.A. Effect of gender and estrous cycle on the pharmacokinetics of ethanol in the rat brain. Alcohol. Clin. Exp. Res. 26 (2002) 165-172
72. Rukstalis M., and de Wit H. Effects of triazolam at three phases of the menstrual cycle. J. Clin. Psychopharmacol. 19 (1999) 450-458
73. Sener E.B., Kocamanoglu S., Cetinkaya M.B., Ustun E., Bildik E., and Tur A. Effects of menstrual cycle on postoperative analgesic requirements, agitation, incidence of nausea and vomiting after gynecological laparoscopy. Gynecol. Obstet. Invest. 59 (2005) 49-53
74. Snively T.A., Ahijevych K.L., Bernhard L.A., and Wewers M.E. Smoking behavior, dysphoric states and the menstrual cycle: results from single smoking sessions and the natural environment. Psychoneuroendocrinology 25 (2000) 677-691
75. Sofuoglu M., Dudish-Poulsen S., Nelson D., Pentel P.R., and Hatsukami D.K. Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp. Clin. Psychopharmacol. 7 (1999) 274-283
76. Sofuoglu M., Babb D.A., and Hatsukami D.K. Effects of progesterone treatment on smoked cocaine response in women. Pharmacol. Biochem. Behav. 72 (2002) 431-435
77. Stoffel E.C., Ulibarri C.M., and Craft R.M. Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats. Pain 103 (2003) 285-302
78. Sundstrom I., Ashbrook D., and Backstrom T. Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study. Psychoneuroendocrinology 22 (1997) 25-38
79. Sundstrom I., Nyberg S., and Backstrom T. Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacology 17 (1997) 370-381
80. Sutker P.B., Goist Jr. K.C., and King A.R. Acute alcohol intoxication in women: relationship to dose and menstrual cycle phase. Alcohol Clin. Exp. Res. 11 (1987) 74-79
81. Sutker P.B., Goist K.C., Allain A.N., and Bugg F. Acute alcohol intoxication: sex comparisons on pharmacokinetic and mood measures. Alcohol Clin. Exp. Res. 11 (1987) 507-512
82. Terner J.M., Barrett A.C., Grossell E., and Picker M.J. Influence of gonadectomy on the antinociceptive effects of opioids in male and female rats. Psychopharmacology (Berl.) 163 (2002) 183-193
83. Terner J.M., Lomas L.M., and Picker M.J. Influence of estrous cycle and gonadal hormone depletion on nociception and opioid antinociception in female rats of four strains. J. Pain 6 (2005) 372-383
84. USGAO [US General Accounting Office], 1990. National Institutes of Health: problems in implementing policy on women in study populations. Statement of Mark V. Nadel, Associate Director, National and Public Health Issues, Human Resources Division, before the Subcommittee on Health and the Environment, Committee on Energy and Commerce. US House of Representatives, June 18th (GAO/T-HRD-90-80).
85. White T.L., Justice A.J., and de Wit H. Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol. Biochem. Behav. 73 (2002) 729-741
86. Yonkers K.A., and Harrison W. The inclusion of women in psychopharmacologic trials. J. Clin. Pharmacol. 13 (1993) 380-382